BlackRock Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $604M | Buy |
8,437,310
+287,090
| +4% | +$20.6M | 0.61% | 29 |
|
|
2016
Q3 | $645M | Buy |
8,150,220
+2,769,646
| +51% | +$219M | 0.66% | 26 |
|
|
2016
Q2 | $449M | Buy |
5,380,574
+1,787,193
| +50% | +$149M | 0.46% | 47 |
|
|
2016
Q1 | $330M | Sell |
3,593,381
-113,090
| -3% | -$10.4M | 0.35% | 71 |
|
|
2015
Q4 | $375M | Buy |
3,706,471
+457,156
| +14% | +$46.3M | 0.4% | 66 |
|
|
2015
Q3 | $319M | Buy |
3,249,315
+1,487,357
| +84% | +$146M | 0.34% | 73 |
|
|
2015
Q2 | $206M | Buy |
1,761,958
+107,518
| +6% | +$12.6M | 0.21% | 118 |
|
|
2015
Q1 | $162M | Sell |
1,654,440
-720,951
| -30% | -$70.7M | 0.17% | 151 |
|
|
2014
Q4 | $224M | Sell |
2,375,391
-64,277
| -3% | -$6.06M | 0.23% | 113 |
|
|
2014
Q3 | $260M | Sell |
2,439,668
-1,820,195
| -43% | -$194M | 0.26% | 93 |
|
|
2014
Q2 | $353M | Sell |
4,259,863
-1,550,984
| -27% | -$129M | 0.33% | 67 |
|
|
2014
Q1 | $412M | Sell |
5,810,847
-1,342,592
| -19% | -$95.1M | 0.4% | 59 |
|
|
2013
Q4 | $537M | Sell |
7,153,439
-1,043,990
| -13% | -$78.4M | 0.52% | 47 |
|
|
2013
Q3 | $515M | Sell |
8,197,429
-137,098
| -2% | -$8.62M | 0.52% | 43 |
|
|
2013
Q2 | $427M | Buy |
+8,334,527
| New | +$427M | 0.45% | 56 |
|